Nagoya Firm Goodman To Commence Drug-Eluting Stent Trials In Japan And Europe
This article was originally published in PharmAsia News
Executive Summary
Nagoya-headquartered medical device maker Goodman plans to start a clinical study for its drug-eluting stent in Japan and Europe in 2012